ClinicalTrials.Veeva

Menu

Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease

S

Slovak Academy of Sciences

Status

Completed

Conditions

Healthy Volunteers
Mild Cognitive Impairment
Subjective Cognitive Impairment
Parkinson Disease

Treatments

Behavioral: exercise
Dietary Supplement: supplementation with placebo
Dietary Supplement: carnosine supplementation
Behavioral: stretching

Study type

Interventional

Funder types

Other

Identifiers

NCT03330470
15-0253

Details and patient eligibility

About

The purpose of this study is to investigate the beneficial effects of regular exercise and the impact of food supplement carnosine on cognitive, motoric and metabolic functions as well as on specific biologically active substances in volunteers with subjective (SCI) or mild (MCI) cognitive impairment, as well as in patients in early stages of Parkinson's disease. The investigators assume the immediate intervention-associated health benefit for volunteers.

Full description

Standard Operating Procedures for patient recruitment, data collection, data management, data analysis routinely used in Biomedical Research Center, Slovak Academy of Sciences, University Hospital Bratislava and Comenius University, Bratislava will be employed. Gait and balance parameters will be examined and analysed at the Department of Behavioural Neuroscience, Centre of Experimental Medicine, Slovak Academy of Sciences, Bratislava, Slovakia Statistical analysis will be employed to address the primary and secondary objectives, as specified in the study protocol.

Enrollment

26 patients

Sex

All

Ages

55 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Signed informed consent
  • Age 55 - 80 years
  • Presence of Subjective Cognitive Impairment (SCI), Mild Cognitive Impairment (MCI) or early stage of Parkinson's Disease (Hoehn-Yahr 1st-2nd stage), assessed by experienced neurologist

Exclusion criteria

  • Serious systemic cardiovascular, hepatic, renal disease, cancer
  • Lack of compliance

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

26 participants in 4 patient groups

exercise and carnosine supplementation
Experimental group
Description:
exercise: participants will be subjected to 4 months of supervised exercise intervention carnosine supplementation: participants will be instructed to take carnosine 2 times daily
Treatment:
Dietary Supplement: carnosine supplementation
Behavioral: exercise
exercise and supplementation with placebo
Experimental group
Description:
exercise: participants will be subjected to 4 months of supervised exercise intervention supplementation with placebo: participants will be instructed to take placebo 2 times daily
Treatment:
Dietary Supplement: supplementation with placebo
Behavioral: exercise
stretching controls and carnosine supplementation
Experimental group
Description:
stretching controls: participants will be subjected to 4 months of supervised stretching program carnosine supplementation: participants will be instructed to take carnosine 2 times daily
Treatment:
Behavioral: stretching
Dietary Supplement: carnosine supplementation
stretching controls and supplementation with placebo
Experimental group
Description:
stretching controls: participants will be subjected to 4 months of supervised stretching program supplementation with placebo: participants will be instructed to take placebo 2 times daily
Treatment:
Behavioral: stretching
Dietary Supplement: supplementation with placebo

Trial contacts and locations

3

Loading...

Central trial contact

Barbara Ukropcová, Assoc. Prof., MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems